It looks like Roundup maker Bayer might see the writing on the wall. After losing three attempts to convince juries that its flagship herbicide Roundup wasn’t causing customers to develop non-Hodgkin’s lymphoma, reports are surfacing of the corporation’s attempts to find a suitable amount to settle the matter.
Information leaked from those said to be familiar with the negotiations indicates that Bayer has offered up to $8 billion to ...
continue reading...
A study released in March of this year may add to Bayer’s troubles as it faces over 11,000 lawsuits alleging a link between the main compound in its Roundup weed killer and non-Hodgkin’s lymphoma. The corporation has already lost three jury trials over the issue and pressure is mounting to reach some sort of settlement.